FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and genetic engineering and represents a promoter/enhancer system for increasing the binding of RNA polymerase 1 with promoter regions, consisting of a translational elongation factor promoter 1α (alpha EF1) linked to 3'-end of the cytomegalovirus enhancer, and a ubequitin C promoter linked to 5'-end of the cytomegalovirus enhancer. Invention relates to an expression vector containing a target protein gene under the control of said system, where the target protein gene is two copies of the darbepoetin alpha gene.
EFFECT: invention enables to effectively implement a method for producing a stable clone of darbepoetin alpha, involving transfection of a cell line with the disclosed vector, selection of a stable darbepoetin producer by selection in a medium with subsequent cloning, cultivation of a stable clone in a nutrient medium.
12 cl, 3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
CHINESE HAMSTER OVARY CELL LINE STRAIN | 2023 |
|
RU2805879C1 |
EUKARYOTIC HOST CELL FOR EXPRESSION OF DARBEPOETIN, EXPRESSION VECTOR AND METHOD OF PRODUCTION OF DARBEPOETIN ALFA | 2013 |
|
RU2523948C1 |
RECOMBINANT PLASMID DNA OF pBiPr-ABIgA2m1F16-ht TO OBTAIN RECOMBINANT IMMUNOGLOBULIN A OF ISOTYPE IgA2m1 | 2016 |
|
RU2671477C2 |
METHOD OF PRODUCING DIMERIC FORM OF MUTANT IGA2M1-ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2023 |
|
RU2822889C1 |
RECOMBINANT PLASMID DNA PBIPR-ABIGA1FI6-HT FOR OBTAINING RECOMBINANT IMMUNOGLOBULIN A IGOTH IGA1 | 2016 |
|
RU2656142C1 |
METHOD OF PRODUCING DIMERIC FORM OF IMMUNOGLOBULIN IGA1-ISOTYPE IN MAMMALIAN CELLS | 2023 |
|
RU2822890C1 |
RECOMBINANT PLASMID DNA pBiIPr-ABIgA1FI6-INTHT FOR OBTAINING RECOMBINANT IGA1 ISOTYPE IMMUNOGLOBULIN | 2016 |
|
RU2664184C2 |
METHOD FOR PRODUCING RECOMBINANT IGA2m1 ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2022 |
|
RU2801178C1 |
HYBRID PROTEIN BASED ON RECOMBINANT HUMAN ERYTHROPOIETIN, HAVING PROLONGED ACTION (VERSIONS), AND METHOD OF ITS PRODUCTION | 2013 |
|
RU2515914C1 |
RECOMBINED PLASMID DNA CODING CHIMERIC ANTIBODY AGAINST HUMAN TUMOUR NECROSIS FACTOR-ALPHA, EUKARYOTIC CELL LINE PRODUCING CHIMERIC ANTIBODY, AND METHOD OF CHIMERIC ANTIBODY OBTAINMENT | 2013 |
|
RU2555533C9 |
Authors
Dates
2024-05-28—Published
2022-04-21—Filed